Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 24:13:836614.
doi: 10.3389/fphar.2022.836614. eCollection 2022.

A Structural and Functional Perspective of Death Receptor 6

Xiuying Ren  1 , Zhi Lin  1 , Wensu Yuan  1
Affiliations
Review

A Structural and Functional Perspective of Death Receptor 6

Xiuying Ren et al. Front Pharmacol. .

Abstract

As a member of the tumor necrosis factor receptor superfamily (TNFRSF), death receptor 6 (DR6) has a similar structural architecture to other family members. The extracellular region of DR6 contains four cysteine-rich domains, followed by a single-pass transmembrane domain and an intracellular region. Since its discovery, DR6 has become an orphan receptor ubiquitously expressed to transduce unique signaling pathways. Although the free ectodomains of β-amyloid precursor protein (APP) can bind to DR6 to induce apoptotic signals, the natural ligands of DR6 still remain largely unknown. In this review, we focus on recent research progress of structural and functional studies on DR6 for better understanding DR6-mediated signaling and the treatment of DR6-related diseases.

Keywords: DR6; co-receptor; death domain; death receptor; signaling.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The structure of DR6 (A) Molecular architecture of human DR6. SP: signal peptide; CRD: cysteine-rich domain; TM: transmembrane sequence; DD: death domain; CARD: caspase activation and recruitment domain. (B) Amino acid sequence of full-length human DR6. The secondary structures of DR6 are shown below the sequence. The red letters indicate the structured elements. N-glycosylation sites are colored in blue and underlined; O-glycosylation sites, green and underlined. A putative leucine zipper motif with a proline-rich sequence is green underlined (C) Ribbon drawing of crystal structure of the DR6-CRDs (PDB ID: 3QO4) (D) Structural comparison between CRDs of DR6 (green) and DcR3 (purple, PDB ID: 3MHD) (E) Structural model of the DR6-TMD. (F) Structural comparison between monomeric TMDs of DR6 (cyan) and p75NTR (dark green, left, PDB ID: 2MIC)/TNFR1(orange, right, PDB ID: 7K7A) (G) Structural model of the DR6-DD. (H) Structural comparison between DDs of DR6 (blue) and p75NTR (yellow, PDB ID: 4F42) (I) Ribbon drawing of the lowest energy structure of C-terminal CARD domain of DR6 (PDB ID: 2DBH) (J) Structural comparison between CARDs of DR6 (green) and Nod1 (dark red, PDB ID: 2NZ7).
FIGURE 2
FIGURE 2
Complex structure between DR6-CRDs and APP-E2 (PDB ID:4YN0) (A). APP-E2 domain is colored in cyan, and CRDs of DR6 are colored in green. (B). Structural comparison between monomeric DR6-CRDs (purple) and the DR6-CRDs (green) from DR6-CRDs:APP-E2 complex.
FIGURE 3
FIGURE 3
Cartoon models of DR6 signaling (A) DR6-mediated intracellular signaling pathways are showed in four different cells, brain endothelial cell, neurons, HeLa, and HEK293T. In brain endothelial cell, DR6 and TROY complex is involved in angiogenesis and BBB formation. They are regulated by Wnt/β-catenin signaling and engage in crosstalk with the VEGF/VEGFR2 signaling pathway. In neuron cells, DR6 can interact with APP or p75NTR to promote neuronal apoptosis and axonal degeneration. In HeLa cells, DR6 can promote mitochondria-dependent apoptosis through membrane protein PSAP. In HEK293T, DR6 can induce NF-kB pathway and promote cell survival through adaptor protein TRADD. (B) Extracellular signaling pathway of sDR6. In MCF-7 cancer cell line, cleavage of the extracellular region of DR6 by the metalloenzyme MMP-14 leads to the formation of sDR6. This soluble protein can hinder the differentiation of monocytes into immature dendritic cells, thereby inhibiting the body’s immune response. In neurons, sDR6 produced by metalloprotease ADAM10 cleavage can trans-act on Schwann cells and inhibit their proliferation and myelination in the PNS. The intracellular domain is released into the cytosol and rapidly degraded by proteasome.
See this image and copyright information in PMC

References

    1. Anderson D. M., Maraskovsky E., Billingsley W. L., Dougall W. C., Tometsko M. E., Roux E. R., et al. (1997). A Homologue of the TNF Receptor and its Ligand Enhance T-Cell Growth and Dendritic-Cell Function. Nature 390 (6656), 175–179. 10.1038/36593 - DOI - PubMed
    1. Andreoli V., Cittadella R., Valentino P., Condino F., La Russa A., Liguori M., et al. (2007). The Role of VLA4 Polymorphisms in Multiple Sclerosis: an Association Study. J. Neuroimmunol. 189 (1-2), 125–128. 10.1016/j.jneuroim.2007.06.015 - DOI - PubMed
    1. Bolger A. P., Anker S. D. (2000). Tumour Necrosis Factor in Chronic Heart Failure: a Peripheral View on Pathogenesis, Clinical Manifestations and Therapeutic Implications. Drugs 60 (6), 1245–1257. 10.2165/00003495-200060060-00002 - DOI - PubMed
    1. Coburger I., Hoefgen S., Than M. E. (2014). The Structural Biology of the Amyloid Precursor Protein APP - a Complex Puzzle Reveals its Multi-Domain Architecture. Biol. Chem. 395 (5), 485–498. 10.1515/hsz-2013-0280 - DOI - PubMed
    1. Colombo A., Hsia H. E., Wang M., Kuhn P. H., Brill M. S., Canevazzi P., et al. (2018). Non-cell-autonomous Function of DR6 in Schwann Cell Proliferation. EMBO J. 37 (7), e97390. 10.15252/embj.201797390 - DOI - PMC - PubMed